Camena Bioscience (private company)

See something wrong or missing? Let us know
Offices:Cambridge
Business model:B2B

Camena Bioscience is a synthetic biology startup from the UK that developed a technology that overcomes these limitations by using a wholly novel enzymatic technology to accurately produce synthetic DNA

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 9.85M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Camena Bioscience

Name Criteria
Sweden Navinci Diagnostics
70%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
France Emulseo
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
Finland FinnAdvance
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
Poland GeneMe
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Sweden Pila Pharma
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
Poland Molecule.one
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
Sweden Nanolyze
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
France Xenothera
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
Sweden Anocca
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
Netherlands Amarna Therapeutics
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one other investor: found 1
Top